nflammatory Bowel Disease and the Risk of Fracture JEERD –

JEERD–PIETER VAN STAA,*,‡,§ CYRUS COOPER,‡ LISTY SAMUELS BRUSSE,* UBERT LEUFKENS,* MUHAMMAD K. JAVAID,‡ and NIGEL K. ARDEN‡ Department of Pharmacoepidemiology and Pharmacotherapy, University of Utrecht, Utrecht, The Netherlands; ‡Medical Research Council nvironmental Epidemiology Unit, Southampton General Hospital, University of Southampton, Southampton, England; and §Procter & Gamble harmaceuticals, Staines, England

[1]  C. Cooper,et al.  Use of Oral Corticosteroids and Risk of Fractures , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[2]  M. Dougados,et al.  Low bone mineral density in patients with inflammatory bowel disease , 1992, Digestive Diseases and Sciences.

[3]  J. Mayberry,et al.  Osteoporosis and Determinants of Bone Density in Patients with Crohn's Disease , 1998, Digestive Diseases and Sciences.

[4]  American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases. , 2003, Gastroenterology.

[5]  D. Felsenberg,et al.  High prevalence of osteoporotic vertebral fractures in patients with Crohn’s disease , 2002, Gut.

[6]  C. Cooper,et al.  The Epidemiology of Corticosteroid-Induced Osteoporosis: a Meta-analysis , 2002, Osteoporosis International.

[7]  L. Melton,et al.  Long-term fracture risk in patients with Crohn's disease: a population-based study in Olmsted County, Minnesota. , 2002, Gastroenterology.

[8]  D. Felsenberg,et al.  Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's disease , 2002, Alimentary pharmacology & therapeutics.

[9]  Peter Vestergaard,et al.  Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. , 2002, American journal of epidemiology.

[10]  W. Bilker,et al.  Validity and completeness of the General Practice Research Database for studies of inflammatory bowel disease , 2002, Pharmacoepidemiology and drug safety.

[11]  F. Sylvester,et al.  Effect of Crohn's Disease on Bone Metabolism In Vitro: A Role for Interleukin‐6 , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  C. Cooper,et al.  Epidemiology of fractures in England and Wales. , 2001, Bone.

[13]  C. Cooper,et al.  Comparison of Calcaneal Ultrasound and DXA to Assess the Risk of Corticosteroid-Induced Osteoporosis: A Cross-sectional Study , 2001, Osteoporosis International.

[14]  P. J. Kelly,et al.  Inflammatory bowel disease: epidemiology and management in an English general practice population , 2000, Alimentary pharmacology & therapeutics.

[15]  C. Bernstein,et al.  The Incidence of Fracture among Patients with Inflammatory Bowel Disease: A Population-Based Cohort Study , 2000, Annals of Internal Medicine.

[16]  E. Schoon,et al.  Bone mineral density in patients with recently diagnosed inflammatory bowel disease. , 2000, Gastroenterology.

[17]  L Abenhaim,et al.  The use of a large pharmacoepidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results , 2000, Pharmacoepidemiology and drug safety.

[18]  S. Laurberg,et al.  Fracture risk is increased in Crohn's disease, but not in ulcerative colitis , 2000, Gut.

[19]  G. Porro,et al.  Altered bone metabolism in inflammatory bowel disease: there is a difference between Crohn’s disease and ulcerative colitis , 2000, Journal of internal medicine.

[20]  E. Schoon,et al.  Osteopenia and osteoporosis in Crohn's disease: prevalence in a Dutch population-based cohort. , 2000, Scandinavian journal of gastroenterology. Supplement.

[21]  B. Wolffenbuttel,et al.  Osteoporosis as a risk in inflammatory bowel disease , 1999 .

[22]  A. Rieber,et al.  [Pathological bone density in chronic inflammatory bowel diseases--prevalence and risk factors]. , 1999, Zeitschrift fur Gastroenterologie.

[23]  K. Mann,et al.  Reduced Bone Mineral Density and Unbalanced Bone Metabolism in Patients with Inflammatory Bowel Disease , 1998, Inflammatory bowel diseases.

[24]  T. Walley,et al.  The UK General Practice Research Database , 1997, The Lancet.

[25]  J. Hyams,et al.  Alterations in bone metabolism in children with inflammatory bowel disease: an in vitro study. , 1997, Journal of pediatric gastroenterology and nutrition.

[26]  J. Jahnsen,et al.  Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. , 1997, Gut.

[27]  I. Forgacs,et al.  Reduced bone density in patients with inflammatory bowel disease. , 1997, Gut.

[28]  M. Manns,et al.  Altered bone metabolism in inflammatory bowel disease. , 1997, The American journal of gastroenterology.

[29]  T. Karttunen,et al.  A controlled study of bone mineral density in patients with inflammatory bowel disease. , 1995, Gut.

[30]  M. Dougados,et al.  Metabolic bone assessment in patients with inflammatory bowel disease. , 1995, Gastroenterology.

[31]  J. Sayre,et al.  Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  W. Hannan,et al.  Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. , 1994, Gastroenterology.

[33]  K. Rickels,et al.  [Osteopenia in chronic inflammatory bowel diseases. Results of a cross-sectional study using quantitative computerized tomography]. , 1994, Leber, Magen, Darm.

[34]  L. Abenhaim,et al.  The quality of information recorded on a UK database of primary care records: A study of hospitalizations due to hypoglycemia and other conditions , 1994 .

[35]  D. Clements,et al.  A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. , 1993, Bone and mineral.

[36]  A. Silman,et al.  The epidemiology of vertebral fractures. European Vertebral Osteoporosis Study Group. , 1993, Bone.

[37]  D. Clements,et al.  Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. , 1992, Scandinavian journal of gastroenterology.

[38]  J. Compston,et al.  Osteoporosis in patients with inflammatory bowel disease. , 1987, Gut.